The provision of health care begins with a practitioner and a patient, but it also depends on a complex network of providers, payors, suppliers, manufacturers, lenders and investors. Our health care attorneys provide counsel to clients in every sector of the health care industry, from the non-profit and for-profit organizations that provide health care to the vendors and financial services firms that supply critical services.
At Mintz Levin, we believe that this broad experience benefits our clients and strengthens our practice. We have gained deep knowledge of the specific business drivers, operational issues, and regulatory challenges that face each type of entity, but we also see the bigger picture. We can anticipate how reforms and regulations in one sector might affect organizations in another, and we understand how significant developments, like the current push for health care reform, will impact the health care industry as a whole.
Our clients include:
- Academic Medical Centers | - Hospitals and Hospital Systems |
- Commercial Insurers | - TRICARE |
- Retail | - Internet/Mail-Order |
- Health Care IT | - Pharmaceutical Products |
- Bond Issuers/Underwriters | - Venture Capital |
Please click on these links to learn more about our services for health care clients in health law, antitrust, health care enforcement defense, communications, employment, labor and benefits, corporate governance and transactions, government law, immigration, intellectual property, real estate, and tax law.
2/10/2012
2/6/2012
2/3/2012
1/31/2012
1/30/2012
1/17/2012
12/19/2011
12/13/2011
12/12/2011
12/5/2011
11/21/2011
11/14/2011
11/7/2011
11/1/2011
10/24/2011
10/17/2011
10/17/2011
10/10/2011
10/3/2011
9/26/2011
9/20/2011
9/13/2011
8/19/2011
8/15/2011
8/8/2011
8/1/2011
7/25/2011
6/21/2011
5/6/2011
4/27/2011
4/15/2011
4/6/2011
4/6/2011
4/5/2011
4/1/2011
3/27/2011
2/3/2011
2/2011
Theresa C. Carnegie and Karen S. Lovitch
G-2 Compliance Report
1/28/2011
1/21/2011
1/18/2011
1/12/2011
12/17/2010
12/17/2010
11/23/2010
11/15/2010
11/4/2010
11/2/2010
10/25/2010
10/13/2010
9/30/2010
9/27/2010
9/23/2010
9/16/2010
9/8/2010
9/1/2010
8/24/2010
8/17/2010
8/9/2010
7/28/2010
7/23/2010
7/13/2010
7/2/2010
6/30/2010
6/30/2010
6/16/2010
5/27/2010
5/26/2010
5/25/2010
5/18/2010
5/17/2010
5/13/2010
5/7/2010
4/27/2010
4/26/2010
4/22/2010
4/21/2010
Hope S. Foster, Sarah A. Kaput and Jennifer E. Williams
The Food and Drug Law Institute
4/20/2010
4/14/2010
4/13/2010
4/5/2010
3/24/2010
3/15/2010
3/9/2010
3/5/2010
2/3/2010
1/20/2010
1/15/2010
1/11/2010
1/4/2010
1/4/2010
1/4/2010
12/31/2009
12/28/2009
12/3/2009
10/29/2009
8/26/2009
8/19/2009
7/20/2009
7/13/2009
7/2/2009
7/1/2009
9/9/2008
7/2008
Nili S. Yolin and M. Daria Niewenhous
Oncology Issues
5/19/2008
2/8/2008
1/2008
Thomas S. Crane
Journal of Health & Life Sciences Law
12/17/2007
Margaret D. Kranz, Andrew B. Roth
New York Law Journal
11/14/2007
11/12/2007
11/1/2007
10/3/2007
9/26/2007
Mintz Levin's Health Law Practice
Bureau of National Affairs
9/25/2007
8/8/2007
6/22/2007
6/22/2007
6/21/2007
6/21/2007
5/15/2007
4/3/2007
4/1/2007
3/21/2007
3/1/2007
2/28/2007
2/27/2007
2/21/2007
2/13/2007
1/25/2007
12/29/2006
Boston Business Journal
12/1/2006
11/1/2006
9/18/2006
9/8/2006
9/1/2006
8/8/2006
7/12/2006
7/1/2006
6/19/2006
6/2/2006
5/1/2006
4/21/2006
4/7/2006
4/1/2006
3/1/2006
2/15/2006
2/14/2006
1/1/2006
1/1/2006
10/25/2005
7/30/2005
5/1/2005
4/21/2005
3/15/2005
11/25/2004
10/14/2004
9/27/2004
7/15/2004
7/1/2004
5/7/2004
4/14/2004
2/2/2004
12/19/2003
12/10/2003
12/8/2003
12/3/2003
11/26/2003
11/3/2003
9/12/2003
7/25/2003
7/21/2003
7/18/2003
7/15/2003
6/26/2003
6/2/2003
5/28/2003
5/21/2003
5/14/2003
3/28/2003
1/1/2003
11/1/2002
9/1/2002
5/1/2002
4/5/2002
4/1/2002
4/1/2002
4/1/2002
3/1/2002
3/1/2002
3/1/2002
3/1/2002
2/1/2002
1/1/2002
2/1/2001
1/1/2001
12/1/2000
11/1/2000
11/1/2000
9/1/2000
6/1/2000
6/1/2000
5/1/2000
4/1/2000
2/1/2000
1/1/2000